Stem cell therapy is an emerging treatment for type 2 diabetes. Although it’s not yet FDA-approved in the United States, it is a rapidly expanding and promising field of research. Stem cells are ...

We may earn commission if you buy from a link. Why Trust Us? Until now, cells dividing by mitosis were thought to grow round and then split into two identical, spherical daughter cells.

In a new study, researchers from the University of Copenhagen have successfully created stem cells that are better at developing into other cell types, like a younger, fitter version of themselves ...

Hideyuki Okano, Clinical trials test the safety of stem-cell therapy for Parkinson's disease, Nature (2025). DOI: 10.1038/d41586-025-00688-x Journal information: Nature ...

The baseline patient characteristics are shown in Table 1 (hematological malignancies and transplants are shown in the Data Supplement [Table S1, online only]). Fig 1. CONSORT diagram. MSC, ...

Mesenchymal stem cells (MSCs) are unique adult stem cells with immunosuppressive properties that also may play a key role in preventing autoimmunity. In a new study, researchers identified metabolic ...

And a baby chimpanzee sips a bottle. The 2024 Nature Photography Contest showcases the complicated beauty and inspiring resiliency of our planet. Photographer Christopher Paetkau took home top ...

NEW YORK, Jan. 16, 2025 /PRNewswire/ -- The Food and Drug Administration (FDA) approved the first mesenchymal stromal cell (MSC) therapy, RYONCIL ®, indicated for steroid-refractory acute graft ...

Mesenchymal stem cells are adult stem cells found in several places in the body, including in the bone marrow, skin, and fat tissue. For over a decade, smaller clinical trials have explored the ...

an allogeneic bone marrow-derived mesenchymal stromal cell therapy, in pediatric patients with SR-aGvHD categorized as Grade B or D, excluding Grade B skin, assessed by the International Blood and ...

The US Food and Drug Administration (FDA) has approved remestemcel-L (Ryoncil, Mesoblast Ltd), an allogeneic bone marrow‒derived mesenchymal stromal cell (MSC) therapy for steroid-refractory ...